Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: J Immunol. 2009 Jun 1;182(11):7163–7171. doi: 10.4049/jimmunol.0803933

Table II.

Genetic analysis of chromosome 17 recombinant lines.

Locusa Recombinant linesb

C57L.M-H2k MA/My.L-H2b
M M M M
R1 R2 R3 R4 R5 R6 R7 R8 R9 R10 R11 R12 R13 R1 R2 R3 R4
D17Mit16 M M L L L L M M M M M L L L M M L
H-2K M M L L L L M M M M ND L L L M M L
17Uva12 M M L L M L M M M M L L L L M M L
17Uva01 M L L L M M M M M M L M M M M M M
H-2D M L L L M M M M ND M L M M M M M M
17Uva03 M L L L M M L M L M L L L M M M M
17Uva06 M L M L M M L L L L L L L M M L M
17Uva09 M L M M M M L L L L L L L M M L M
D17Mit10 L L L M M M L L L L L L L M L L M
a

Chromosome 17 locus markers (see Table I) used to determine MA/My (M) or C57L (L) alleles for the recombinant chromosome in each line are shown. Some alleles are not determined (ND).

b

Recombinant lines were generated on C57L (denoted as R) or MA/My (denoted as MR) backgrounds.

HHS Vulnerability Disclosure